07/10/2026
Strengthening aDSM for Safer, More Person-Centred DR-TB Care
How can we strengthen adverse drug reaction monitoring while ensuring that people receiving treatment for drug-resistant tuberculosis are heard, supported, and protected?
Join RAHAMA as we participate in an upcoming webinar convened by KNCV Tuberculosis Foundation to explore practical experiences, lessons learned, and innovative approaches to strengthening active drug safety monitoring and management (aDSM) within TB programmes.
The webinar will bring together experiences from Nigeria, Ethiopia, and Mozambique, highlighting how health systems, pharmacovigilance structures, community organisations, and civil society partners are working together to improve the detection, reporting, and management of adverse events as new DR-TB medicines and shorter treatment regimens are introduced.
For us at RAHAMA, the conversation is particularly important because safer TB treatment is not only about medicines, it is also about systems, communities, information, responsiveness, and ensuring that people affected by TB have a voice in their care.
📅 7 October 2026
🕒 12:00–14:00 CET | 11:00–13:00 WAT
🔗 Register: https://lnkd.in/ezZZgsgh
ℹ️ More information: https://lnkd.in/eAxDwxTJ
This webinar is part of the Unitaid-funded ASCENT DR-TB Project, led by KNCV Tuberculosis Foundation.
We look forward to contributing to and learning from this important conversation on strengthening pharmacovigilance and community-centred approaches to DR-TB care.
CommunityEngagement PatientCentredCare TBCommunity TBAdvocacy RAHAMA Unitaid KNCV